KOLINPHARMA® obtains its 5th patent in the USA for MIELSAX® !
6 Oct 2020
MILESAX® was granted because of the recognized innovation and uniqueness of the composition, with muscle relaxant and anti-inflammatory activity.
To date, Kolinpharma has obtained 4 industrial patents in Italy, 3 patents in 12 new European countries beyond Italy, 5 patents in the United States and 1 in Israel, a conquest that is a source of great pride in countries considered a worldwide reference in scientific research and of great importance in the world of nutraceuticals which testifies to the seriousness and accuracy research and confirms the ability of the R&D team to study innovative formulations and develop effective products, based on the most current scientific evidence in the various reference areas.
-file109046.JPG)
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation